Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Blicklé

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
La Revue De Medecine Interne|November 8, 2003
[Type 2 diabetes mellitus pathogenesis: new therapeutic managements?]J-F Blicklé
Diabetes & Metabolism|June 1, 2006
Meglitinide analogues: a review of clinical data focused on recent trialsJ F Blicklé
Diabetes & Metabolism|January 18, 2006
Management of hypertension in elderly diabetic patientsJ F Blicklé
Diabetes & Metabolism|July 14, 2001
[Thiazolidinediones: clinical data and perspectives]J F Blicklé
Diabetes & Metabolism|November 25, 2003
[Should type 2 diabetes prevention pharmacological studies prompt us to change our prescription habits?]J F Blicklé
La Revue De Medecine Interne|January 1, 1991
[Europe of the universities is running at last!]J M Brogard, J F Blicklé
La Revue De Medecine Interne|August 6, 1999
[Why did the diagnostic criteria for diabetes change?]J F Blicklé, J M Brogard
European Journal of Internal Medicine|August 19, 2007
Detrimental action of thiazolidinediones on bone (rebuttal)J W F Elte, J F Blicklé
European Journal of Internal Medicine|January 16, 2007
Thiazolidinediones for the treatment of type 2 diabetesJ W F Elte, J F Blicklé
Diabetes & Metabolism|September 30, 2000
Contribution of total and intact proinsulins to hyperinsulinism in subjects with obesity, impaired glucose tolerance or type 2 diabetesJ F Blicklé, R Sapin, E Andrès
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
La Revue De Medecine Interne|November 8, 2003
[Type 2 diabetes mellitus pathogenesis: new therapeutic managements?]J-F Blicklé
Diabetes & Metabolism|June 1, 2006
Meglitinide analogues: a review of clinical data focused on recent trialsJ F Blicklé
Diabetes & Metabolism|January 18, 2006
Management of hypertension in elderly diabetic patientsJ F Blicklé
Diabetes & Metabolism|July 14, 2001
[Thiazolidinediones: clinical data and perspectives]J F Blicklé
Diabetes & Metabolism|November 25, 2003
[Should type 2 diabetes prevention pharmacological studies prompt us to change our prescription habits?]J F Blicklé
La Revue De Medecine Interne|January 1, 1991
[Europe of the universities is running at last!]J M Brogard, J F Blicklé
La Revue De Medecine Interne|August 6, 1999
[Why did the diagnostic criteria for diabetes change?]J F Blicklé, J M Brogard
European Journal of Internal Medicine|August 19, 2007
Detrimental action of thiazolidinediones on bone (rebuttal)J W F Elte, J F Blicklé
European Journal of Internal Medicine|January 16, 2007
Thiazolidinediones for the treatment of type 2 diabetesJ W F Elte, J F Blicklé
Diabetes & Metabolism|September 30, 2000
Contribution of total and intact proinsulins to hyperinsulinism in subjects with obesity, impaired glucose tolerance or type 2 diabetesJ F Blicklé, R Sapin, E Andrès
Pageof 4